Due to an equipment failure the availability of albumin is currently limited

18-Apr-2017 - Germany

Biotest has started to inform its customers about an expected albumin supply shortage within the coming months. This is due to an equipment failure in the production of an albumin intermediate. The equipment failure has already been fixed.

In accordance with the relevant authorities, Biotest decided that all batches which have been produced in the affected equipment and have already been supplied, must not be used until the issue is clarified.

Additional necessary analyses are currently conducted. The company expect results within the next four weeks. Biotest will take further steps on the basis of these analysis data. The impact on sales and annual results for the Biotest Group are only assessable afterwards.

Other news from the department manufacturing

Most read news

More news from our other portals

So close that even
molecules turn red...